BrMT
BrMT (Bromodomain and Extra-Terminal motif) proteins are a family of proteins that play a crucial role in the regulation of gene expression. These proteins are characterized by the presence of one or more bromodomains, which are specialized protein domains that recognize and bind to acetylated lysine residues on histone tails. This binding is essential for the regulation of chromatin structure and function, thereby influencing transcriptional activation and repression.
Structure[edit | edit source]
BrMT proteins typically contain one or more bromodomains and an extra-terminal (ET) domain. The bromodomains are responsible for recognizing acetylated lysine residues, while the ET domain is involved in protein-protein interactions. The structure of BrMT proteins allows them to act as "readers" of the histone code, interpreting post-translational modifications on histones to regulate gene expression.
Function[edit | edit source]
The primary function of BrMT proteins is to regulate gene expression by modulating chromatin structure. They achieve this by binding to acetylated histones, which can either promote or inhibit the transcription of specific genes. BrMT proteins are involved in various cellular processes, including cell cycle regulation, DNA repair, and development.
Clinical Significance[edit | edit source]
BrMT proteins have been implicated in several diseases, including cancer, inflammatory diseases, and neurological disorders. In cancer, for example, aberrant expression or mutations in BrMT proteins can lead to dysregulation of gene expression, contributing to tumorigenesis. As a result, BrMT proteins are considered potential targets for therapeutic intervention, and several small-molecule inhibitors targeting bromodomains are currently under investigation.
Research and Therapeutic Potential[edit | edit source]
The study of BrMT proteins is an active area of research, with ongoing efforts to understand their role in various biological processes and diseases. The development of bromodomain inhibitors has shown promise in preclinical studies, and some compounds are undergoing clinical trials for the treatment of cancer and other diseases.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD